Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
03/2003
03/27/2003US20030059469 Protecting the carboxylic acid group of the drug molecule, adding to the drug molecule a chlorinated polyanhydride linker, deprotecting by exposing the linked drug molecules to heat or vacuum, acetylating to produce monomer, polymerizing
03/27/2003US20030059456 Intravaginal drug delivery devices for the administration of an antimicrobial agent
03/27/2003US20030059442 Attenuated microorganisms for the treatment of infection
03/27/2003US20030059441 Unmarked mutation is a mutated nucleotide sequence introduced into mycobacterium where sequence does not contain selectable marker such as gene conferring antibiotic resistance to recombinant mycobacterium incorporating mutated sequence
03/27/2003US20030056788 Partial liquid breathing of fluorocarbons
03/27/2003CA2492826A1 Encapsulation of unmethylated cpg-containing oligonucleotides into virus-like particles: method of preparation and use
03/27/2003CA2492823A1 In vivo activation of antigen presenting cells for enhancement of immune responses induced by virus like particles
03/27/2003CA2461073A1 6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
03/27/2003CA2461072A1 Compounds which inhibit the release of inflammatory cytokines
03/27/2003CA2461071A1 Spirocyclic-6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
03/27/2003CA2461056A1 Hiv-gag codon-optimised dna vaccines
03/27/2003CA2460947A1 6-o-carbamate-11,12-lacto-ketolide antimicrobials
03/27/2003CA2460808A1 Immune response associated proteins
03/27/2003CA2460783A1 Bioprecursors for percutaneous application
03/27/2003CA2460704A1 Use of peptides comprising post-translational modifications in the treatment of autoimmune pathologies
03/27/2003CA2460646A1 Antibacterial macrocycles
03/27/2003CA2460558A1 Crustaceans as production systems for therapeutic proteins
03/27/2003CA2460360A1 Systematical administration of some oxazolidinones, e.g. linezolid, for the treatment for ocular infections
03/27/2003CA2460358A1 Hydroxyfattysulfonic acid analogs
03/27/2003CA2460334A1 Microfabricated nanopore device for sustained release of therapeutic agent
03/27/2003CA2460321A1 Chemokines as adjuvants of immune response
03/27/2003CA2460263A1 Hydroxyeicosenoic acid analogs
03/27/2003CA2460151A1 Cytokine receptor
03/27/2003CA2459773A1 Enamel matrix protein compositions for modulating immune response
03/27/2003CA2459140A1 Protein modification and maintenance molecules
03/27/2003CA2457563A1 Interleukin-12 as a veterinary vaccine adjuvant
03/27/2003CA2456193A1 Compositions comprising immunostimulatory oligonucleotides and uses thereof to enhance fc receptor-mediated immunotherapies
03/27/2003CA2454023A1 Dna-pk inhibitors in the treatment of retroviral mediated diseases
03/27/2003CA2429005A1 Substituted benzoic acid derivatives having nf-kb inhibiting action
03/26/2003WO2002026978A1 Novel proteins, genes encoding them and method of using the same
03/26/2003EP1295890A1 Novel pyrazine derivatives or salts thereof, pharmaceutical composition containing the same, and production intermediates thereof
03/26/2003EP1295879A1 Medicinal compositions containing propenone derivatives
03/26/2003EP1295874A2 Retroviral protease inhibiting compounds
03/26/2003EP1295603A1 The process of extracting from haw-pit by dry distillation and its device
03/26/2003EP1295127A2 Inter-alpha-trypsin as a marker for sepsis
03/26/2003EP1295126A2 Hepatitis c viral antigen immunoassay detection systems
03/26/2003EP1294924A2 Method for identifying medically valuable active substances
03/26/2003EP1294904A1 Heterodimeric fusion proteins
03/26/2003EP1294893A2 Modification of hepatitis b core antigen
03/26/2003EP1294892A2 Assembly of wild-type and chimeric influenza virus-like particles (vlps)
03/26/2003EP1294891A2 Transport peptides derived from erns protein, cytotoxic rnase of ribosome-inactivating protein or a rsv g-protein and analogues thereof
03/26/2003EP1294890A2 Peptides for the preparation of vaccines against bordetella pertussis and bordetella parapertussis
03/26/2003EP1294874A2 Cd154 variants and uses thereof
03/26/2003EP1294858A2 Respiratory syncytial virus vaccines expressing protective antigens from promotor-proximal genes
03/26/2003EP1294771A2 IMMUNIZATION OF DAIRY CATTLE WITH CHIMERIC GAPC PROTEIN AGAINST i STREPTOCOCCUS /i INFECTION
03/26/2003EP1294770A1 Human igm antibodies with the capability of inducing remyelination, and diagnostic and therapeutic uses thereof particularly in the central nervous system
03/26/2003EP1294765A2 Il-17 molecules and uses thereof
03/26/2003EP1294754A1 Interferon-alpha induced gene
03/26/2003EP1294750A2 Acid-modified arabinogalactan protein composition
03/26/2003EP1294745A2 Antimicrobial peptides and methods of use thereof
03/26/2003EP1294740A2 Chemically-modified antimicrobial peptides, compositions and methods of production and use
03/26/2003EP1294735A2 Methods and compositions for treating flaviviruses and pestiviruses
03/26/2003EP1294730A2 Novel cephalosporin compounds and process for preparing the same
03/26/2003EP1294728A1 HMG-CoA REDUCTASE INHIBITORS AND METHOD
03/26/2003EP1294726A2 Improvements in and relating to chromophores
03/26/2003EP1294720A1 Non-nucleoside reverse transcriptase inhibitors
03/26/2003EP1294717A2 A thiazine oxazolidinone
03/26/2003EP1294713A2 Compounds possessing antibacterial, antifungal or antitumor activity
03/26/2003EP1294711A2 1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as as modulators of protein kinases
03/26/2003EP1294707A2 Thiophene derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
03/26/2003EP1294705A1 Synthesis of cyclic compounds
03/26/2003EP1294699A2 Modulators of tnf- alpha signalling
03/26/2003EP1294696A2 Hmg-coa reductase inhibitors and their use as medicaments for the treatment of cholesterol related diseases
03/26/2003EP1294691A1 Serine protease inhibitors
03/26/2003EP1294690A2 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
03/26/2003EP1294682A1 Acylphenyl urea derivatives, methods for the production thereof and use thereof as a medicament
03/26/2003EP1294646A2 Devices and method for production of traceable immunizing drinking water, other liquids and gas
03/26/2003EP1294409A2 Membrane-permeant peptide complexes for medical imaging
03/26/2003EP1294405A2 Prodrug compounds cleavable by thimet oligopeptidase
03/26/2003EP1294403A2 Tripeptide prodrug compounds
03/26/2003EP1294400A1 Vaccine against foot-and-mouth disease
03/26/2003EP1294399A2 Methods and composition for oral vaccination
03/26/2003EP1294398A2 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
03/26/2003EP1294397A2 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
03/26/2003EP1294395A1 A COMBINATION PRODUCT COMPRISING MELAGATRAN AND A FACTOR VIIa INHIBITOR
03/26/2003EP1294387A2 Use of phyllanthus constituents for treating or preventing infections caused by flaviviridae
03/26/2003EP1294383A2 Oral compositions comprising antimicrobial agents
03/26/2003EP1294380A1 A method for treating septic shock
03/26/2003EP1294373A1 Pharmaceutical disinfectants comprising usnic acid and essential oils
03/26/2003EP1294371A1 Medium chain fatty acids applicable as antimicrobial agents
03/26/2003EP1294365A2 Cytotoxic agents comprising single-stranded and/or looped dna
03/26/2003EP1294361A2 Compositions and methods to improve the oral absorption of antimicrobial agents
03/26/2003EP1185528A4 Inhibitors of il-12 production
03/26/2003EP1181010A4 Pharmaceutical chewing gum formulations
03/26/2003EP1173215A4 Over-coated chewing gum formulations
03/26/2003EP1149089B1 PROCESS TO PREPARE TETRAHYDROTHIOPYRAN-o-FLUORINATED CARBAMATES
03/26/2003EP1077703B1 Oral medicinal preparations with reproducible release of the active ingredient gatifloxacin or its pharmaceutically suitable salts or hydrates
03/26/2003EP0882041B1 Piperazinonephenyloxazolidinone derivatives and their use as antibacterial agents
03/26/2003EP0863757B1 2-substituted aryl pyrroles, compositions containing such compounds and methods of use
03/26/2003EP0806941B1 Low rigidity liposomal antibacterial composition
03/26/2003EP0801640B1 2,5-diamino-3,4-disubstituted-1,6-diphenylhexane isosteres comprising benzamide, sulfonamide and anthranilamide subunits and methods of using same
03/26/2003EP0793656B1 Novel benzyl pyrimidines
03/26/2003EP0610436B9 Hepatitis-c virus testing
03/26/2003CN1406336A Method of detecting substance inhibiting type III secretion mechanism of bacterium and the function of secretory protein thereof
03/26/2003CN1406278A Expression of recombinant mature lysostaphin
03/26/2003CN1406277A Recombinant attenuation of PRRSV
03/26/2003CN1406274A Novel lactobacillus paracasei subsp. paracasei strain antibacterial against nelicobacter pylori and escherichia coli 157:H7
03/26/2003CN1406243A Memno peptides, a process for their preparation and their use
03/26/2003CN1406237A Novel benzosultam oxazolidinone antibacterial agents
03/26/2003CN1406233A Medicine for viral diseases
1 ... 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 1219 1220 1221 1222 1223 1224 1225 ... 1798